Thank you to all who attended the our 12th annual, 2014 PamJam benefit party. Information regarding the 2015 PamJam will be available soon. The PamJam’s primary beneficiary is The Leukemia & Lymphoma Society, with funds going towards selected research projects.

The Pamela B. Katten Memorial Leukemia Research foundation is currently selling tickets to Beautiful: The Carole King Musical which tells the inspiring true story of Carole King’s remarkable rise to stardom, from being part of a hit songwriting team with her husband, Gerry Goffin, to her relationship with fellow writers and best friends, Cynthia Weil and Barry Mann, to becoming one of the most successful solo acts in popular music history. 

The musical will play in Chicago at the ORIENTAL THEATRE from December 2015 through February 2016We have a limited number of great seats for sale for the 8PM performance Saturday, December 12, 2015.  Profits from the ticket sales will go to help us sponsor teams of extremely dedicated researchers whose common goal is to find a cure for blood cancers.  Your contribution will help to save lives.The seats are located in the dress circle section of the theatre and are priced at $210 each seat.  The excess over the ticket face price will constitute a charitable deduction of $100 on your part. For more information regarding ticket sales, please email us at info@pamjam.org

Pam Katten passed away in September 2002 at the age of 41 from Acute Myelogenous Leukemia (AML). The PamJam honors Pam’s courageous battle against Leukemia with music, family, friends and a purpose.  PamJam raises money to cure cancer and provide patient assistance.

We are proud to state that since its first event in November 2003, the PamJam has raised over $2,000,000 for blood cancer research.

The Need For A Cure:
Blood cancers affect a growing number of Americans each year. Last year, more than 137,000 new cases of leukemia, lymphoma, Hodgkin’s disease and myeloma were diagnosed in the United States. An estimated 1,000,000 Americans are presently living with one of these cancers and over 60,000 people will die this year from one of these diseases. Leukemia is the number one cancer killer of children under the age of 14. In Illinois, an estimated 5,000 new patients will be diagnosed this year with a blood cancer.

About The Leukemia & Lymphoma Society (LLS):
The Leukemia & Lymphoma Society is the world’s largest voluntary health organization dedicated to curing leukemia, lymphoma Hodgkin’s disease and myeloma and improving the quality of life of patients and their families. LLS was founded in 1949 by the de Villiers family of New York after they lost their only child, Robert, to leukemia at the age of 16. Over the past 60 plus years, LLS has invested more than $750 million in promising scientists conducting cutting edge research aimed at discovering a sure for leukemia, lymphoma and related blood cancers.

In addition to research, the Society provides a wide range of patient services programs including financial aid, family support groups, peer to peer counseling, pediatric support programs, information and referral services and advocacy.

Over the past 60 years, LLS has gone from talking about leukemia to talking about cancer; from finding a cure for leukemia to finding a cure for cancer.

Since its founding, The Leukemia & Lymphoma Society has impacted the scientific community with discoveries in cancer genetics, immunology and cell biology. LLS helped to fund the discovery of chemotherapy, sequential chemo-radiation, antibody therapeutics, and bone marrow and stem cell transplantation. These new treatments, pioneered in blood cancer research, are now used for treating many other malignancies including breast, skin, lung, colon and pancreatic cancers. An investment in blood cancer research today will impact the greater cancer community.

If you have any questions, please contact the Pamela B. Katten Memorial Leukemia Research Foundation using our online form.

Comments are closed.